• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acta Psychiatr Scand . Severe mental illness is associated with increased mortality and severe course of COVID-19

tetano

Editor, Senior Moderator
Acta Psychiatr Scand


. 2021 Apr 24.
doi: 10.1111/acps.13309. Online ahead of print.
Severe mental illness is associated with increased mortality and severe course of COVID-19


Carlo Alberto Barcella[SUP] 1 [/SUP], Christoffer Polcwiartek[SUP] 2 [/SUP], Grimur H?gnason Mohr[SUP] 1 3 [/SUP], Gethin Hodges[SUP] 1 [/SUP], Kathrine S?ndergaard[SUP] 1 [/SUP], Casper Bang[SUP] 4 5 [/SUP], Mikkel Porsborg Andersen[SUP] 5 [/SUP], Emil Fosb?l[SUP] 6 [/SUP], Lars K?ber[SUP] 6 [/SUP], Morten Schou[SUP] 1 [/SUP], Christian Torp-Pedersen[SUP] 2 5 [/SUP], Lars Vedel Kessing[SUP] 7 8 [/SUP], Gunnar Gislason[SUP] 1 9 [/SUP], Kristian Kragholm[SUP] 2 [/SUP]



Affiliations

Abstract

Objective: Psychiatric disorders have been associated with unfavorable outcome following respiratory infections. Whether this also applies to coronavirus disease 2019 (COVID-19) has been scarcely investigated.
Methods: Using the Danish administrative databases, we identified all patients with a positive real-time reverse transcription-polymerase chain reaction test for COVID-19 in Denmark up to and including January 2, 2021. Multivariable Cox regression was used to calculate 30-day absolute risk and average risk ratio (ARR) for the composite endpoint of death from any cause and severe COVID-19 associated with psychiatric disorders, defined using both hospital diagnoses and redemption of psychotropic drugs.
Results: We included 144,321patients with COVID-19. Compared with patients without psychiatric disorders, the standardized ARR of the composite outcome was significantly increased for patients with severe mental illness including schizophrenia spectrum disorders 2.43 (95% confidence interval [CI], 1.79-3.07), bipolar disorder 2.11 (95% CI, 1.25-2.97), unipolar depression 1.70 (95% CI, 1.38-2.02), and for patients who redeemed psychotropic drugs 1.70 (95% CI, 1.48-1.92). No association was found for patients with other psychiatric disorders 1.13 (95% CI, 0.86-1.38). Similar results were seen with the outcomes of death or severe COVID-19. Among the different psychiatric subgroups, patients with schizophrenia spectrum disorders had the highest 30-day absolute risk for the composite outcome 3.1% (95% CI, 2.3-3.9%), death 1.2% (95% CI, 0.4-2.0%) and severe COVID-19 2.7% (95% CI, 1.9-3.6%).
Conclusion: Schizophrenia spectrum disorders, bipolar disorder, unipolar depression and psychotropic drug redemption are associated with unfavourable outcomes in patients with COVID-19.

Keywords: Covid-19; bipolar disorder; depression; respiratory infection; schizophrenia; unfavourable outcome.
 
Back
Top Bottom